SLC27A5 and metabolic dysfunction-associated steatotic liver disease: Among these targets where expression and/or activity modulate lipid homeostasis, there is evidence of the BA-mediated link between FXR and FATP5 in the liver and lipid specific manner, which provide an idea about their involvement in NAFLD 16.